1. We have investigated the mechanism of action of the novel anti-diabetic agent mitiglinide (S 2140...
The ATP-sensitive K+ channels opener (KATPCO), P1075 [N-cyano-N'-(1,1-dimethylpropyl)-N?-3-pyridylgu...
Sulphonylurea drugs are the therapy of choice for treating neonatal diabetes (ND) caused by mutation...
Contains fulltext : 110913.pdf (publisher's version ) (Closed access)Sulfonylurea ...
Sulphonylureas are a class of drugs widely used to treat non-insulin-dependent diabetes mellitus. Th...
Contains fulltext : 23443___.PDF (publisher's version ) (Open Access
Sulphonylureas stimulate insulin secretion from pancreatic β-cells primarily by closing ATP-sensitiv...
Contains fulltext : 23802___.PDF (publisher's version ) (Open Access
Many cells are equipped with so-called potassium (K+) channels which have an important role in maint...
The novel sulfonylthiourea 1-[[5-[2-(5-chloro-o-anisamido)-ethyl]-2-methoxyphenyl]sulfonyl]-3-methyl...
1. We examined the effect of the sulphonylurea glimepiride on three types of recombinant ATP-sensiti...
Contains fulltext : 57698.pdf (publisher's version ) (Closed access)Sepsis-induced...
Sulfonylureas stimulate insulin secretion in type-2 diabetic patients by blocking ATP-sensitive (K(A...
<div><p>Sulphonylurea drugs stimulate insulin secretion from pancreatic β-cells primarily by inhibit...
Sulphonylurea drugs stimulate insulin secretion from pancreatic β-cells primarily by inhibiting ATP ...
1. We have investigated the mechanism of action of the novel anti-diabetic agent mitiglinide (S 2140...
The ATP-sensitive K+ channels opener (KATPCO), P1075 [N-cyano-N'-(1,1-dimethylpropyl)-N?-3-pyridylgu...
Sulphonylurea drugs are the therapy of choice for treating neonatal diabetes (ND) caused by mutation...
Contains fulltext : 110913.pdf (publisher's version ) (Closed access)Sulfonylurea ...
Sulphonylureas are a class of drugs widely used to treat non-insulin-dependent diabetes mellitus. Th...
Contains fulltext : 23443___.PDF (publisher's version ) (Open Access
Sulphonylureas stimulate insulin secretion from pancreatic β-cells primarily by closing ATP-sensitiv...
Contains fulltext : 23802___.PDF (publisher's version ) (Open Access
Many cells are equipped with so-called potassium (K+) channels which have an important role in maint...
The novel sulfonylthiourea 1-[[5-[2-(5-chloro-o-anisamido)-ethyl]-2-methoxyphenyl]sulfonyl]-3-methyl...
1. We examined the effect of the sulphonylurea glimepiride on three types of recombinant ATP-sensiti...
Contains fulltext : 57698.pdf (publisher's version ) (Closed access)Sepsis-induced...
Sulfonylureas stimulate insulin secretion in type-2 diabetic patients by blocking ATP-sensitive (K(A...
<div><p>Sulphonylurea drugs stimulate insulin secretion from pancreatic β-cells primarily by inhibit...
Sulphonylurea drugs stimulate insulin secretion from pancreatic β-cells primarily by inhibiting ATP ...
1. We have investigated the mechanism of action of the novel anti-diabetic agent mitiglinide (S 2140...
The ATP-sensitive K+ channels opener (KATPCO), P1075 [N-cyano-N'-(1,1-dimethylpropyl)-N?-3-pyridylgu...
Sulphonylurea drugs are the therapy of choice for treating neonatal diabetes (ND) caused by mutation...